C2orf66
gene geneOn this page
Also known as UNQ6411
Summary
C2orf66 (chromosome 2 open reading frame 66, HGNC:33809) is a protein-coding gene on chromosome 2q33.1, encoding Uncharacterized protein C2orf66 (Q6UXQ4).
Predicted to be located in extracellular region.
Source: NCBI Gene 401027 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_213608
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33809 |
| Approved symbol | C2orf66 |
| Name | chromosome 2 open reading frame 66 |
| Location | 2q33.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | UNQ6411 |
| Ensembl gene | ENSG00000187944 |
| Ensembl biotype | protein_coding |
| Entrez | 401027 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000342506
RefSeq mRNA: 1 — MANE Select: NM_213608
NM_213608
CCDS: CCDS2317
Canonical transcript exons
ENST00000342506 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001366204 | 196804417 | 196805408 |
| ENSE00001368967 | 196807424 | 196807622 |
| ENSE00003902316 | 196809214 | 196809355 |
Expression profiles
Bgee: expression breadth ubiquitous, 123 present calls, max score 94.30.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0443 / max 25.0367, expressed in 11 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 33046 | 0.0443 | 11 |
Top tissues by expression
129 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.30 | gold quality |
| pituitary gland | UBERON:0000007 | 76.74 | gold quality |
| adenohypophysis | UBERON:0002196 | 75.57 | gold quality |
| hypothalamus | UBERON:0001898 | 72.86 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 64.54 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 63.78 | gold quality |
| substantia nigra | UBERON:0002038 | 63.32 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 63.03 | gold quality |
| left adrenal gland | UBERON:0001234 | 62.72 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 62.67 | gold quality |
| amygdala | UBERON:0001876 | 61.93 | gold quality |
| left testis | UBERON:0004533 | 61.90 | gold quality |
| temporal lobe | UBERON:0001871 | 61.43 | gold quality |
| nucleus accumbens | UBERON:0001882 | 61.21 | gold quality |
| right uterine tube | UBERON:0001302 | 61.17 | gold quality |
| right testis | UBERON:0004534 | 61.16 | gold quality |
| Ammon’s horn | UBERON:0001954 | 61.05 | gold quality |
| testis | UBERON:0000473 | 60.60 | gold quality |
| right adrenal gland | UBERON:0001233 | 60.52 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 59.49 | gold quality |
| stromal cell of endometrium | CL:0002255 | 59.10 | gold quality |
| right atrium auricular region | UBERON:0006631 | 58.94 | gold quality |
| adrenal gland | UBERON:0002369 | 58.81 | gold quality |
| islet of Langerhans | UBERON:0000006 | 58.67 | gold quality |
| omental fat pad | UBERON:0010414 | 57.36 | gold quality |
| brain | UBERON:0000955 | 57.32 | gold quality |
| skin of leg | UBERON:0001511 | 56.98 | gold quality |
| skin of abdomen | UBERON:0001416 | 56.97 | gold quality |
| caudate nucleus | UBERON:0001873 | 56.88 | gold quality |
| zone of skin | UBERON:0000014 | 56.82 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.27 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
60 targeting C2orf66, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-4671-3P | 99.88 | 72.46 | 1045 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-4760-5P | 99.80 | 69.88 | 1619 |
| HSA-MIR-8076 | 99.78 | 68.52 | 1170 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
| HSA-MIR-646 | 99.68 | 67.84 | 1645 |
| HSA-MIR-29B-2-5P | 99.67 | 68.98 | 1726 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pgap1 | ENSDARG00000062465 |
| mus_musculus | Gm34066 | ENSMUSG00000109809 |
| rattus_norvegicus | C9h2orf66 | ENSRNOG00000067303 |
| drosophila_melanogaster | PGAP1 | FBGN0029789 |
| caenorhabditis_elegans | WBGENE00011835 |
Paralogs (1): PGAP1 (ENSG00000197121)
Protein
Protein identifiers
Uncharacterized protein C2orf66 — Q6UXQ4 (reviewed: Q6UXQ4)
All UniProt accessions (1): A0A5K1VW65
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
RefSeq proteins (1): NP_998773* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031699 | DUF4720 | Family |
Pfam: PF15846
UniProt features (2 total): signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6UXQ4-F1 | 72.23 | 0.09 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 17 (showing top):
FREAC3_01, RFX1_02, MIR4666A_3P, MIR338_5P, MIR3978, MIR29B_2_5P, MIR4760_5P, MIR4735_5P, MIR8061, MIR5583_3P, MIR20B_3P, BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP, BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP, OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP, SMAD3_Q6
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
282 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C2orf66 | CCDC190 | Q86UF4 | 515 |
| C2orf66 | TMEM217B | A0A494BZU4 | 480 |
| C2orf66 | TMEM217 | Q8N7C4 | 479 |
| C2orf66 | Q8NG57 | Q8NG57 | 447 |
| C2orf66 | C2CD4B | A6NLJ0 | 366 |
| C2orf66 | RPF2 | Q9H7B2 | 360 |
| C2orf66 | SLC41A2 | Q96JW4 | 350 |
| C2orf66 | PIGT | Q969N2 | 348 |
| C2orf66 | PGAP3 | Q96FM1 | 348 |
| C2orf66 | PIGK | Q92643 | 348 |
| C2orf66 | GPAA1 | O43292 | 347 |
| C2orf66 | CSNK1G1 | Q9HCP0 | 338 |
| C2orf66 | PIGS | Q96S52 | 320 |
| C2orf66 | MPZL2 | O60487 | 307 |
| C2orf66 | PLA2G4C | Q9UP65 | 305 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C2orf66 | EFCAB2 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (2): C2orf66 (Positive Genetic), EFCAB2 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GTC6, A0A2U3Y4D7, A0A2Y9HRM2, G5BQH4, G5BWH8, G8F204, P01257, P01261, P02652, P02656, P06759, P0CE37, P0CE39, P0CF78, P0DJD2, P0DJG2, P0DKV2, P0DKV3, P0DKV4, P0DM95, P0DM96, P0DMP9, P0DMR2, P0DMT9, P0DN36, P0DP50, P0DP84, P0DP85, P0DP86, P0DP87, P0DTQ3, P0DTQ5, P0DTR6, P0DTS5, P18656, P18659, P33622, P40148, P41547, P70160
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
194 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:196807623:C:CC | acceptor_gain | 1.0000 |
| 2:196809208:TCTTA:T | donor_loss | 1.0000 |
| 2:196809209:CTTA:C | donor_loss | 1.0000 |
| 2:196809210:TTAC:T | donor_loss | 1.0000 |
| 2:196809211:TA:T | donor_loss | 1.0000 |
| 2:196809212:ACC:A | donor_loss | 1.0000 |
| 2:196809213:C:CA | donor_loss | 1.0000 |
| 2:196807019:TTCA:T | donor_gain | 0.9900 |
| 2:196807621:AA:A | acceptor_gain | 0.9900 |
| 2:196809212:A:AC | donor_gain | 0.9900 |
| 2:196809213:C:CC | donor_gain | 0.9900 |
| 2:196805409:CTGA:C | acceptor_loss | 0.9800 |
| 2:196805410:T:G | acceptor_loss | 0.9800 |
| 2:196807418:TTTTA:T | donor_loss | 0.9800 |
| 2:196807419:TTTA:T | donor_loss | 0.9800 |
| 2:196807420:TTAC:T | donor_loss | 0.9800 |
| 2:196807421:TAC:T | donor_loss | 0.9800 |
| 2:196807422:A:T | donor_loss | 0.9800 |
| 2:196807423:CCTG:C | donor_loss | 0.9800 |
| 2:196807620:AAA:A | acceptor_gain | 0.9800 |
| 2:196807622:ACTA:A | acceptor_loss | 0.9700 |
| 2:196807624:T:C | acceptor_loss | 0.9700 |
| 2:196809213:CCAG:C | donor_gain | 0.9700 |
| 2:196805406:CAC:C | acceptor_gain | 0.9600 |
| 2:196807622:ACT:A | acceptor_gain | 0.9600 |
| 2:196807623:CTA:C | acceptor_gain | 0.9600 |
| 2:196807624:T:A | acceptor_gain | 0.9600 |
| 2:196807618:AAAAA:A | acceptor_gain | 0.9500 |
| 2:196807620:AAACT:A | acceptor_gain | 0.9500 |
| 2:196807621:AACTA:A | acceptor_gain | 0.9500 |
AlphaMissense
646 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:196809247:C:A | W47C | 0.883 |
| 2:196809247:C:G | W47C | 0.883 |
| 2:196809249:A:G | W47R | 0.878 |
| 2:196809249:A:T | W47R | 0.878 |
| 2:196807617:G:C | F60L | 0.874 |
| 2:196807617:G:T | F60L | 0.874 |
| 2:196807619:A:G | F60L | 0.874 |
| 2:196807620:A:C | F59L | 0.832 |
| 2:196807620:A:T | F59L | 0.832 |
| 2:196807622:A:G | F59L | 0.832 |
| 2:196809223:G:C | N55K | 0.737 |
| 2:196809223:G:T | N55K | 0.737 |
| 2:196809244:C:A | K48N | 0.732 |
| 2:196809244:C:G | K48N | 0.732 |
| 2:196807609:A:T | L63H | 0.712 |
| 2:196809220:T:A | R56S | 0.710 |
| 2:196809220:T:G | R56S | 0.710 |
| 2:196809239:A:T | L50H | 0.704 |
| 2:196807597:A:G | F67S | 0.693 |
| 2:196807618:A:C | F60C | 0.685 |
| 2:196809248:C:A | W47L | 0.679 |
| 2:196807609:A:G | L63P | 0.677 |
| 2:196807587:T:A | R70S | 0.673 |
| 2:196807587:T:G | R70S | 0.673 |
| 2:196807566:A:C | F77L | 0.666 |
| 2:196807566:A:T | F77L | 0.666 |
| 2:196807568:A:G | F77L | 0.666 |
| 2:196807604:C:G | A65P | 0.664 |
| 2:196807621:A:G | F59S | 0.661 |
| 2:196807618:A:G | F60S | 0.657 |
dbSNP variants (sampled 300 via entrez): RS1000089402 (2:196829813 T>C), RS1000090416 (2:196806575 G>T), RS1000141937 (2:196823365 G>A), RS1000142798 (2:196806329 C>G), RS1000173692 (2:196832004 G>A), RS1000191013 (2:196810463 T>C), RS1000335206 (2:196824236 T>C), RS1000356019 (2:196826834 C>G,T), RS1000368279 (2:196819869 G>C,T), RS1000475518 (2:196806614 G>T), RS1000763016 (2:196806963 G>A), RS1000778598 (2:196819424 T>A), RS1000881019 (2:196825860 G>T), RS1001091435 (2:196825432 T>C), RS1001209384 (2:196829702 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010396_207 | Gut microbiota (bacterial taxa, hurdle binary method) | 4.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 1-hydroxypyrene | decreases expression | 1 |
| 3,4,5,4’-tetramethoxystilbene | affects expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Cisplatin | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.